Ayşe Salihoğlu

654 total citations
71 papers, 320 citations indexed

About

Ayşe Salihoğlu is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Ayşe Salihoğlu has authored 71 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 30 papers in Genetics and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Ayşe Salihoğlu's work include Chronic Lymphocytic Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (19 papers) and Lymphoma Diagnosis and Treatment (15 papers). Ayşe Salihoğlu is often cited by papers focused on Chronic Lymphocytic Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (19 papers) and Lymphoma Diagnosis and Treatment (15 papers). Ayşe Salihoğlu collaborates with scholars based in Türkiye and Russia. Ayşe Salihoğlu's co-authors include Teoman Soysal, Muhlis Cem Ar, Ahmet Emre Eşkazan, Zafer Başlar, Burhan Ferhanoğlu, Nükhet Tüzüner, Gülen Hatemi, İbrahim Hatemı, Tuğrul Elverdi and Sinem Nihal Esatoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Ayşe Salihoğlu

56 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayşe Salihoğlu Türkiye 10 146 102 89 70 65 71 320
Seçkin Çağırgan Türkiye 9 187 1.3× 58 0.6× 67 0.8× 29 0.4× 35 0.5× 45 329
Andrea Duminuco Italy 11 128 0.9× 142 1.4× 42 0.5× 26 0.4× 17 0.3× 60 344
Émilie Chalayer France 11 110 0.8× 56 0.5× 31 0.3× 61 0.9× 18 0.3× 32 245
Constance Guillaud France 8 274 1.9× 179 1.8× 10 0.1× 127 1.8× 36 0.6× 18 525
A. Gibofsky United States 2 81 0.6× 41 0.4× 19 0.2× 206 2.9× 37 0.6× 3 320
B-S Cho South Korea 13 408 2.8× 72 0.7× 96 1.1× 28 0.4× 19 0.3× 18 508
Paul Legendre France 10 19 0.1× 34 0.3× 46 0.5× 68 1.0× 66 1.0× 29 314
Irena Đjunić Serbia 10 230 1.6× 81 0.8× 60 0.7× 9 0.1× 23 0.4× 32 306
Yali Zhou China 10 67 0.5× 72 0.7× 15 0.2× 17 0.2× 14 0.2× 30 268
Pravas Mishra India 12 266 1.8× 179 1.8× 32 0.4× 29 0.4× 6 0.1× 43 379

Countries citing papers authored by Ayşe Salihoğlu

Since Specialization
Citations

This map shows the geographic impact of Ayşe Salihoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayşe Salihoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayşe Salihoğlu more than expected).

Fields of papers citing papers by Ayşe Salihoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayşe Salihoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayşe Salihoğlu. The network helps show where Ayşe Salihoğlu may publish in the future.

Co-authorship network of co-authors of Ayşe Salihoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Ayşe Salihoğlu. A scholar is included among the top collaborators of Ayşe Salihoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayşe Salihoğlu. Ayşe Salihoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elverdi, Tuğrul, et al.. (2025). Extramedullary disease in multiple myeloma at diagnosis and over the course of the disease. International Journal of Hematology. 122(1). 73–82.
2.
Çavuşoğlu, Yüksel, Omaç Tüfekçioğlu, Ebru Özpelit, et al.. (2024). Current barriers and recommendations on the diagnosis of transthyretin amyloid cardiomyopathy: a Delphi study. Frontiers in Cardiovascular Medicine. 11. 1299261–1299261. 1 indexed citations
3.
Akkuş, Erman, Ayşe Salihoğlu, Ömür Gökmen Sevindik, et al.. (2024). P-194 A Germline Variant of BNIP1 Gene (rs28199) is Associated with Familial Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 24. S149–S150. 1 indexed citations
4.
Akkuş, Erman, Yıldız Aydın, Sevgi Kalayoğlu Beşışık, et al.. (2023). Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases. British Journal of Haematology. 204(3). 931–938. 3 indexed citations
5.
Elverdi, Tuğrul, et al.. (2022). Successful Treatment Of Bulky Abdominal Plasmacytomas With Radiotherapy and Pomalidomide. Eastern Journal Of Medicine. 27(2). 330–332.
6.
Yılmaz, Umut, Tuğrul Elverdi, Ayşe Salihoğlu, et al.. (2022). Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic. Current Problems in Cancer. 46(6). 100913–100913. 1 indexed citations
7.
Öngören, Şeniz, et al.. (2022). A clinicopathological experience in acute myeloid leukemia: Effects of clinical data and status of FLT3, CEBPA and NPM1 on prognosis. Indian Journal of Pathology and Microbiology. 65(3). 642–642.
8.
Yücesan, Emrah, Özden Hatırnaz Ng, Fevzi Yalniz, et al.. (2020). Copy-number variations in adult patients with chronic immune thrombocytopenia. Expert Review of Hematology. 13(11). 1277–1287. 3 indexed citations
9.
Balkan, İ̇lker İnanç, Ayşe Salihoğlu, Yusuf Emre Özdemir, et al.. (2020). An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality. Annals of Hematology. 99(8). 1925–1932. 24 indexed citations
10.
Salihoğlu, Ayşe, Teoman Soysal, Ìhsan Karadoǧan, et al.. (2019). Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience. Annals of Hematology. 99(2). 301–307. 5 indexed citations
11.
Demirkesen, Cüyan, et al.. (2019). Blastic Plasmacytoid Dendritic Cell Neoplasia: A Single Center Experience. Turkish Journal of Hematology. 37(1). 48–52. 2 indexed citations
12.
Erbilgin, Yücel, Ahmet Emre Eşkazan, Özden Hatırnaz Ng, et al.. (2018). Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. Leukemia & lymphoma. 60(1). 200–207. 11 indexed citations
13.
Salihoğlu, Ayşe, et al.. (2017). Fatal gastrointestinal bleeding and perforated duodenal ulcer: a rare complication of deferasirox in a patient with liver cirrhosis. Biomedical Research-tokyo. 28(12). 5620–5622. 2 indexed citations
14.
Salihoğlu, Ayşe, Ahmet Emre Eşkazan, Muhlis Cem Ar, et al.. (2017). Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience. Blood. 130. 5349–5349.
15.
16.
Yalniz, Fevzi, Ayşe Salihoğlu, Muhlis Cem Ar, et al.. (2017). Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed-Refractory to IMiDs and Proteasome Inhibitors. Turkish Journal of Hematology. 34(3). 233–238. 2 indexed citations
17.
Eşkazan, Ahmet Emre, Mahir Cengız, Muhlis Cem Ar, et al.. (2016). Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. Journal of Clinical Pathology. 69(9). 810–816. 3 indexed citations
18.
Alagöz, Selma, et al.. (2015). Assessment of Anemia and Quality of Life in Patients With Renal Transplantation. Transplantation Proceedings. 47(10). 2875–2880. 10 indexed citations
19.
Salihoğlu, Ayşe, Tuğrul Elverdi, Ìhsan Karadoǧan, et al.. (2014). Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. Annals of Hematology. 94(3). 415–420. 22 indexed citations
20.
Salihoğlu, Ayşe, et al.. (2012). Breast schwannoma in a patient with diffuse large B-cell lymphoma: a case report. Journal of Medical Case Reports. 6(1). 423–423. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seçkin Çağırgan Breakdown of academic impact, for papers by Andrea Duminuco Breakdown of academic impact, for papers by Émilie Chalayer Breakdown of academic impact, for papers by Constance Guillaud Breakdown of academic impact, for papers by A. Gibofsky Breakdown of academic impact, for papers by B-S Cho Breakdown of academic impact, for papers by Paul Legendre Breakdown of academic impact, for papers by Irena Đjunić Breakdown of academic impact, for papers by Yali Zhou Breakdown of academic impact, for papers by Pravas Mishra
Rankless by CCL
2026